Advances in Targeted and Systemic Therapy for Salivary Gland Carcinomas: Current Options and Future Directions

Salivary gland carcinomas (SGCs) represent a rare and heterogeneous group of malignancies accounting for 3–6% of all head and neck cancers. While surgical resection and radiotherapy remain the standard for locoregional control, systemic treatment is indicated for recurrent or metastatic disease. Adv...

Täydet tiedot

Bibliografiset tiedot

Päätekijät:	Sushanth Sreenivasan, Rahim A. Jiwani, Richard White, Veli Bakalov, Ryan Moll, Joseph Liput, Larisa Greenberg
Aineistotyyppi:	Artigo
Kieli:	Inglês
Julkaistu:	MDPI AG 2025-04-01
Sarja:	Current Oncology
Aiheet:	salivary gland carcinoma targeted therapy head and neck tumors immunotherapy pleomorphic adenoma chemotherapy
Linkit:	https://www.mdpi.com/1718-7729/32/4/232
Tagit:	Lisää tagi Ei tageja, Lisää ensimmäinen tagi!